BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity
- 4 June 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 43 (3) , sbw077-672
Abstract
Reduced expression of Brain-Derived Neurotrophic Factor (BDNF) has been implicated in the pathophysiology of schizophrenia. The BDNF Val66Met polymorphism, which results in deficient activity-dependent secretion of BDNF, is associated with clinical features of schizophrenia. We investigated the effect of this polymorphism on Prepulse Inhibition (PPI), a translational model of sensorimotor gating which is disrupted in schizophrenia. We utilized humanized BDNFVal66Met (hBDNFVal66Met) mice which have been modified to carry the Val66Met polymorphism, as well as express humanized BDNF in vivo. We also studied the long-term effect of chronic corticosterone (CORT) exposure in these animals as a model of history of stress. PPI was assessed at 30ms and 100ms interstimulus intervals (ISI). Analysis of PPI at the commonly used 100ms ISI identified that, irrespective of CORT treatment, the hBDNFVal/Met genotype was associated with significantly reduced PPI. In contrast, PPI was not different between hBDNFMet/Met and hBDNFVal/Val genotype mice. At the 30ms ISI, CORT treatment selectively disrupted sensorimotor gating of hBDNFVal/Met heterozygote mice but not hBDNFVal/Val or hBDNFMet/Met mice. Analysis of startle reactivity revealed that chronic CORT reduced startle reactivity of hBDNFVal/Val male mice by 51%. However, this was independent of the effect of CORT on PPI. In summary, we provide evidence of a distinct BDNFVal66Met heterozygote-specific phenotype using the sensorimotor gating endophenotype of schizophrenia. These data have important implications for clinical studies where, if possible, the BDNFVal/Met heterozygote genotype should be distinguished from the BDNFMet/Met genotype.Keywords
Funding Information
- National Health and Medical Research Council (1044777)
This publication has 64 references indexed in Scilit:
- BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulationFrontiers in Cellular Neuroscience, 2013
- BDNF Val66Met and cognition: all, none, or some? A meta‐analysis of the genetic associationGenes, Brain and Behavior, 2011
- Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant TreatmentNeuropsychopharmacology, 2009
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology AspectsSchizophrenia Bulletin, 2009
- Recapitulation and Reversal of a Persistent Depression‐like Syndrome in RodentsCurrent Protocols in Neuroscience, 2009
- Sensorimotor Gating of Schizophrenia Patients Depends on Catechol O-Methyltransferase Val158Met PolymorphismSchizophrenia Bulletin, 2008
- Realistic expectations of prepulse inhibition in translational models for schizophrenia researchPsychopharmacology, 2008
- BDNF Val66Met variant and age of onset in schizophreniaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Genetic Modulation of BDNF Signaling Affects the Outcome of Axonal Competition In VivoCurrent Biology, 2007
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006